Literature DB >> 23929250

Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.

Lynette Denny1, Isaac Adewole, Rose Anorlu, Greta Dreyer, Manivasan Moodley, Trudy Smith, Leon Snyman, Edwin Wiredu, Anco Molijn, Wim Quint, Gunasekaran Ramakrishnan, Johannes Schmidt.   

Abstract

In sub-Saharan Africa, invasive cervical cancer (ICC) incidence and mortality are among the highest in the world. This cross-sectional epidemiological study assessed human papillomavirus (HPV) prevalence and type distribution in women with ICC in Ghana, Nigeria, and South Africa. Cervical biopsy specimens were obtained from women aged ≥ 21 years with lesions clinically suggestive of ICC. Histopathological diagnosis of ICC was determined by light microscopy examination of hematoxylin and eosin stained sections of paraffin-embedded cervical specimens; samples with a confirmed histopathological diagnosis underwent HPV DNA testing by polymerase chain reaction. HPV-positive specimens were typed by reverse hybridization line probe assay. Between October 2007 and March 2010, cervical specimens from 659 women were collected (167 in Ghana, 192 in Nigeria and 300 in South Africa); 570 cases were histologically confirmed as ICC. The tumor type was identified in 551/570 women with ICC; squamous cell carcinoma was observed in 476/570 (83.5%) cases. The HPV-positivity rate in ICC cases was 90.4% (515/570). In ICC cases with single HPV infection (447/515 [86.8%]), the most commonly detected HPV types were HPV16 (51.2%), HPV18 (17.2%), HPV35 (8.7%), HPV45 (7.4%), HPV33 (4.0%) and HPV52 (2.2%). The prevalence of single and multiple HPV infections seemed higher among HIV-positive women and HPV type distribution appeared to differ according to tumor type and HIV status. In conclusion, HPV16, 18, 45 and 35 were the most common HPV types in sub-Saharan African women with ICC and HPV infections were more common in HIV-positive women.
© 2013 UICC.

Entities:  

Keywords:  human papillomavirus; invasive cervical cancer; sub-Saharan Africa

Mesh:

Substances:

Year:  2013        PMID: 23929250     DOI: 10.1002/ijc.28425

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  63 in total

1.  Viral DNA load of high-risk human papilloma virus is closely associated with the grade of cervical lesions.

Authors:  Guqun Shen; Jingxin Cheng; Yan Wang; Ping Zhou; Guoqing Zhang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Performance of vaginal self-sampling for human papillomavirus testing among women living with HIV in Botswana.

Authors:  Tamara Elliott; Racquel E Kohler; Barati Monare; Neo Moshashane; Kehumile Ramontshonyana; Charles Muthoga; Adriane Wynn; Rebecca Howett; Rebecca Luckett; Chelsea Morroni; Doreen Ramogola-Masire
Journal:  Int J STD AIDS       Date:  2019-09-27       Impact factor: 1.359

3.  Cervical HPV natural history among young Western Cape, South African women: The randomized control EVRI Trial.

Authors:  Staci L Sudenga; B Nelson Torres; Matthys H Botha; Michele Zeier; Martha E Abrahamsen; Richard H Glashoff; Susan Engelbrecht; Maarten F Schim Van der Loeff; Louvina E Van der Laan; Siegfried Kipping; Douglas Taylor; Anna R Giuliano
Journal:  J Infect       Date:  2015-10-19       Impact factor: 6.072

4.  Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial.

Authors:  Lynette J Menezes; Ubin Pokharel; Staci L Sudenga; Matthys H Botha; Michele Zeier; Martha E Abrahamsen; Richard H Glashoff; Susan Engelbrecht; Maarten F Schim van der Loeff; Louvina E van der Laan; Siegfried Kipping; Douglas Taylor; Anna R Giuliano
Journal:  Sex Transm Infect       Date:  2017-05-10       Impact factor: 3.519

5.  Temporal trends in the epidemiology of cervical cancer in South Africa (1994-2012).

Authors:  Gbenga Olorunfemi; Ntombizodwa Ndlovu; Gwinyai Masukume; Admire Chikandiwa; Pedro T Pisa; Elvira Singh
Journal:  Int J Cancer       Date:  2018-08-07       Impact factor: 7.396

6.  Human Papillomavirus Genotypes in Invasive Cervical Carcinoma in HIV-Seropositive and HIV-Seronegative Women in Zimbabwe.

Authors:  Washington Mudini; Joel M Palefsky; Martin J Hale; Michael Z Chirenje; Rudo Makunike-Mutasa; Fiona Mutisi; Alltalents Murahwa; Altini Mario
Journal:  J Acquir Immune Defic Syndr       Date:  2018-09-01       Impact factor: 3.731

7.  Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan Africa.

Authors:  Nelly Mugo; Nana Akosua Ansah; Deborah Marino; Alfred Saah; Elizabeth I O Garner
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Prevalence and Risk Factors for Genital Human Papillomavirus Infections Among Women in Southwest Nigeria.

Authors:  Y T Nejo; D O Olaleye; G N Odaibo
Journal:  Arch Basic Appl Med       Date:  2018-05-04

9.  High prevalence of human papillomaviruses in Ghanaian pregnant women.

Authors:  Marco H Schulze; Fabian M Völker; Raimond Lugert; Paul Cooper; Kai Hasenclever; Uwe Groß; Herbert Pfister; Steffi Silling
Journal:  Med Microbiol Immunol       Date:  2016-09-06       Impact factor: 3.402

10.  Barriers to Cervical Cancer Screening in Burkina Faso: Needs for Patient and Professional Education.

Authors:  Salomon Compaore; Charlemagne M R Ouedraogo; Seni Koanda; Gleb Haynatzki; Robert M Chamberlain; Amr S Soliman
Journal:  J Cancer Educ       Date:  2016-12       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.